SEC Form 4 · accession 0001144204-19-013796
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Schrepfer
Officer — SVP - New Bus Dev & Spec Sales
Period of report
Mar 12, 2019
Accepted (ET)
Mar 14, 2019 · 6:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2019 | M | 5,642 | $28.76 | A | 53,484 | D | |
| Common Stock | Mar 12, 2019 | S | 5,642 | $64.4414 | D | 47,842 | D | |
| Common Stock | Mar 12, 2019 | M | 1,503 | $33.00 | A | 49,345 | D | |
| Common Stock | Mar 12, 2019 | S | 1,503 | $64.50 | D | 47,842 | D | |
| Common Stock | Mar 13, 2019 | M | 4,651 | $33.00 | A | 52,493 | D | |
| Common Stock | Mar 13, 2019 | S | 4,651 | $64.4261 | D | 47,842 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $28.76 | Mar 12, 2019 | M | 5,642 | D | — | Aug 19, 2024 | Common Stock | — | 608 | D |
| Option to PurchaseF2 | $33.00 | Mar 12, 2019 | M | 1,503 | D | — | Mar 31, 2024 | Common Stock | 1,503 | 8,497 | D |
| Option to PurchaseF2 | $33.00 | Mar 13, 2019 | M | 4,651 | D | — | Mar 31, 2024 | Common Stock | 4,651 | 3,846 | D |
Explanation of responses
- F1Option vests and are exercisable over a four year period beginning on the first anniversary of the August 20, 2014.
- F2Option vests and are exercisable over a four year period beginning on the first anniversary of the April 1, 2014.